Summary
Specific [3H] GBR 12935 binding was performed on striatal tissue (caudate nucleus) obtained post-mortem from brains of schizophrenic patients and matched controls. Scatchard analysis of left and right hemisphere caudate tissue was performed on each individual subject. Kd and Bmax values were obtained by linear regression analysis of Scatchard plots. The results indicated no change in either the density or the affinity of the dopamine uptake site between schizophrenics and controls. Comparison of left and right hemisphere data also failed to demonstrate any asymmetry in the populations of dopamine uptake sites in both groups studied.
The results do not support the hypothesis of a functional alteration of presynaptic dopamine systems in the caudate nucleus in schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Crow TJ, Owen F, Cross AJ, Ferrier N, Johnstone EC, McCreadie RM, Owens DGC, Poulter M (1981) Neurotransmitter enzymes and receptors in post-mortem brain in schizophrenia: evidence that an increase in D2 dopamine receptors is associated with the Type 1 syndrome. In: Riederer P, Usdin E (eds) Transmitter biochemistry of human brain tissue. Macmillan, London, pp 85–96
Haberland N, Hetey L (1987) Studies in post-mortem dopamine uptake II. Alterations of the synaptosomal catecholamine uptake in post-mortem brain regions in schizophrenia. J Neural Transm 68: 303–313
Janowsky A, Berger P, Vocci F, Skolnick P, Paul SM, Labarca R (1986) Characterization of sodium-dependent [3H]GBR 12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex. J Neurochem 46: 1272–1276
Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornykiewicz O (1978) Binding of3H neuroleptics and3H apomorphine in schizophrenic brain. Nature 274: 897–900
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Mackay AVP, Iversen LL, Rossor M, Spokes E, Arregui A, Creese I, Snyder SH (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39: 991–997
Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley G (1978) Increased dopamine receptor sensitivity in schizophrenia. Lancet ii: 223–226
Reynolds GP (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305: 527–529
Reynolds GP (1985) Neurochemical studies in human postmortem brain tissue. In: Boulton AA, Baker GB (eds) Neuromethods, vol I. Humana, Clifton, NJ, pp 477–496
Reynolds GP, Riederer P, Jellinger K, Gabriel K (1981) Dopamine receptors and schizophrenia: the neuroleptic drug problem. Neuropharmacology 20: 1319–1320
Reynolds GP, Czudek C (1987) Neurochemical lateralily of the limbic system in schizophrenia. In: Takahasi R, Flor-Henry P, Gruzelier J, Niwa S (eds) Cerebral dynamics laterality and psychopathology. Elsevier, Amsterdam, pp 451–456
Reynolds GP, Czudek C, Bzowej N, Seeman P (1987) Dopamine receptor asymmetry in schizophrenia. Lancet i: 979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Czudek, C., Reynolds, G.P. [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia. J. Neural Transmission 77, 227–230 (1989). https://doi.org/10.1007/BF01248935
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01248935